Press releases
- GSK and iTeos Therapeutics announce development and commercialisation collaboration for EOS-448, an anti-TIGIT monoclonal antibody, enabling novel next-generation immuno-oncology combinations
- Significant and Sustained Drop in Teen and Adult Immunization Rates During Pandemic, Study Shows
- GSK to showcase scientific advances and progress in oncology at ASCO and EHA
Tweets from GSK US
-
GSKUS @GSKUS
Today marks the start of the @US_FDA’s inaugural National Black Family Cancer Awareness Week! To help spread awareness about the impact of cancer on Black families or to learn more about this important initiative, visit gsk.to/35x3jHm #BlackFamCan
about 2 days ago
-
GSKUS @GSKUS
Meet our #MedicinalChemistry team at @EWOC8 next week. The conference emphasizes the importance of supporting & elevating women in #OrganicChemistry. Join Paul, VP & Global Head of Medicinal Chemistry, at the “Meet the Sponsor” session on 6/24. Details: gsk.to/3iW5KuC
about 2 days ago
-
GSKUS @GSKUS
#DYK the symptoms of uncontrolled #asthma? Learn more about asthma and how to better recognize the symptoms.
about 2 days ago
